UTI유티아이

UTI is deep in losses, with the share price down about 92% over the past year and heavy dilution-related filings.

UTI makes tempered glass camera covers for phones and tablets, with Samsung Electronics as its main customer. Over the trailing twelve months to H1 2026 it reported revenue of ₩20.0B against an operating loss of ₩58.1B, and the shares closed at ₩1,930 on 2026-10-16, a market value of about ₩41.6B.

What stands out

• Trailing revenue of ₩20.0B is roughly flat with 2025 at ₩20.0B, but the operating loss widened from ₩48.3B in 2025 to ₩58.1B on a trailing basis.
• Free cash flow is negative ₩97.3B on a trailing basis, against cash of ₩2.9B, and the data shows no borrowings figure.
• Liabilities are 194.6% of equity, and ROE is -25% on a trailing basis.
• Recent filings include several convertible bond and conversion price adjustments, a CEO change and a loan extension decision.
• Foreign ownership fell from 13.9% to 10.7% over about 60 days, while retail investors were net buyers over the last 20 trading days.

What to watch

• The shareholders' meeting notices and amendments filed in recent weeks, including agenda details not shown in the data.
• Further conversion price adjustments and any cash needs tied to the convertible bonds and the loan extension.
• Upcoming results and whether the operating loss narrows; the data does not include forecasts.